NIH-funded research R01 grant

Using blood tests to help diagnose stroke faster in African Americans

Official title: Blood transcriptomics as CT adjuvant to exclude hemorrhage in acute stroke

Funded at Morehouse School of Medicine · NIH-10866379 · Data updated 2026-11-12

This study is looking at a new blood test that uses RNA to help doctors quickly and accurately diagnose strokes, especially in African American patients, so they can get the right treatment faster.

More Stroke research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMorehouse School of Medicine
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJuly 15, 2020
Project endApril 30, 2026
Funding year2024
Award (this year)$538,145
NIH project number5R01NS112422-05
Project IDNIH-10866379 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are African American individuals experiencing symptoms of an acute stroke.

Less likely to help

Patients who do not identify as African American or those who are not experiencing acute stroke symptoms may not benefit from this research.

What this research studies

This research investigates a blood-based biomarker assay that utilizes RNA sequencing to accurately diagnose strokes, particularly in African American populations. The study aims to enhance the speed of obtaining results through innovative sequencing technologies, which is crucial for timely treatment with thrombolytic therapy. By correlating the accuracy of the test with factors such as sex and race, the research seeks to ensure that minority populations are adequately represented in stroke diagnostics. The goal is to provide emergency room physicians with a reliable tool to confirm CT scan results, thereby facilitating quicker treatment decisions.

Why it matters

Potential benefit: If successful, this research could significantly reduce the time to administer life-saving stroke treatments, ultimately lowering mortality rates and improving recovery outcomes.

How similar studies have gone: Previous research has shown promise in using blood biomarkers for stroke diagnosis, but this specific approach focusing on minority populations is relatively novel.

Where this research is happening

  • Morehouse School of Medicine
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Meller, Robert — Morehouse School of Medicine
  • Study coordinator: Meller, Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.